# Fulvestrant

NDC: 68001-484
Generic name: Fulvestrant
Labeler / Manufacturer: BluePoint Laboratories
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Abbreviated NDA (generic)
Dosage form: INJECTION, SOLUTION
Routes: INTRAMUSCULAR
Marketing started: 20210301

FDA application: ANDA210044

## Active ingredients

- FULVESTRANT: 250 mg/5mL

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"68001-484"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=68001-484
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=bc7b4eac-3b63-53d2-e053-2995a90ad5e7